Finally, we demonstrated that circUPF2 promoted the expression of SLC7A11 in vivo, and exosomes carrying circUPF2 dramatically attenuated the suppressive effect of sorafenib on HCC xenograft tumors. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.